The results of the study, carried out by researchers from Hospital Clínic-IDIBAPS and CIBERES, will make it possible to design new therapies for chro1
Regenerating and protecting pancreatic beta cells, which are responsible for producing and secreting insulin, are two of the areas of research being1
Treatment with gene therapy, however, reverses the damage caused by deposits of α-synuclein in the neuron circuits and alleviates neuropsychiatric sy1
The document establishes the basis for the exploitation and development of patented technology, owned by six research centers, including IDIBAPS.
Researchers from the Hospital Clínic-IDIBAPS, the Research Institute of the Hospital de Sant Pau – IIB Sant Pan and the CIBERER confirm that the mole1
Researchers from the Hospital Clínic-IDIBAPS, IDIBELL and CIBERSAM have developed a smartphone app that allows anxiety to be assessed continuously an1
Researchers at Hospital Clínic-IDIBAPS have observed changes in the phosphorylation pattern of certain proteins associated with a mutation in the gen1
Current tools to predict the risk of infarction or stroke have limited sensitivity, which is why research has focused on the identification of biomar1
The IDIBAPS platform has 2 scanners, a 3-T scanner and a 7-T scanner, and provides image processing services and consulting on project design.
Researchers from Hospital Clínic-IDIBAPS have published the document, which addresses the psychological treatment of the disease.
